Rxo (RXO) Receivables - Other (2021 - 2025)

Rxo (RXO) has reported Receivables - Other for 5 consecutive years, with $26.0 million the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Receivables - Other rose 52.94% year-over-year to $26.0 million; the trailing twelve-month figure through Dec 2025 stood at $26.0 million (up 52.94% YoY), and the FY2025 full-year result was $26.0 million, up 52.94% from the prior year.
• Receivables - Other rose to $26.0 million in Q4 2025 per RXO's latest filing, from $17.0 million in the prior quarter.
• Across five years, Receivables - Other topped out at $26.0 million in Q4 2025 and bottomed at $5.0 million in Q3 2022.
• Historically, Receivables - Other has averaged $13.8 million across 5 years, with a median of $11.0 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Receivables - Other soared 54.55% in 2024, then soared 52.94% in 2025.
• Over 5 years, Receivables - Other stood at $10.0 million in 2021, then plunged by 50.0% to $5.0 million in 2022, then soared by 120.0% to $11.0 million in 2023, then jumped by 54.55% to $17.0 million in 2024, then surged by 52.94% to $26.0 million in 2025.
• According to Business Quant data, Receivables - Other over the past three periods registered $26.0 million, $17.0 million, and $11.0 million for Q4 2025, Q4 2024, and Q4 2023 respectively.